[ad_1]
Up to date Jan. 15, 2024 3:33 pm ET
Apple is eradicating a blood-oxygen sensor from a few of its smartwatches to get round a patent dispute associated to the expertise, a step more likely to keep away from additional gross sales disruptions however one which will elevate questions in regards to the firm’s push into well being.
The corporate halted gross sales of some watch fashions briefly final month after a U.S. import ban went into impact stemming from an October ruling by the U.S. Worldwide Commerce Fee. The commerce company discovered Apple had violated the patents of medical-technology firm Masimo associated to the blood-oxygen device. Gross sales resumed briefly in current weeks pending a authorized assessment.
Copyright ©2024 Dow Jones & Firm, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
[ad_2]
Source link
